| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K9 trimethyltransferase activity | 1.63e-05 | 5 | 26 | 2 | GO:0140949 | |
| GeneOntologyMolecularFunction | histone H3K9 methyltransferase activity | 1.26e-04 | 13 | 26 | 2 | GO:0046974 | |
| Domain | Cyclophilin-type_PPIase | 3.85e-04 | 21 | 26 | 2 | IPR024936 | |
| Domain | Pro_isomerase | 4.23e-04 | 22 | 26 | 2 | PF00160 | |
| Domain | - | 4.23e-04 | 22 | 26 | 2 | 2.40.100.10 | |
| Domain | Cyclophilin-type_PPIase_dom | 4.23e-04 | 22 | 26 | 2 | IPR002130 | |
| Domain | Cyclophilin-like_dom | 4.23e-04 | 22 | 26 | 2 | IPR029000 | |
| Domain | CSA_PPIASE_1 | 4.23e-04 | 22 | 26 | 2 | PS00170 | |
| Domain | CSA_PPIASE_2 | 4.23e-04 | 22 | 26 | 2 | PS50072 | |
| Domain | SET | 1.48e-03 | 41 | 26 | 2 | PF00856 | |
| Domain | SET | 1.86e-03 | 46 | 26 | 2 | SM00317 | |
| Domain | SET_dom | 2.19e-03 | 50 | 26 | 2 | IPR001214 | |
| Domain | SET | 2.19e-03 | 50 | 26 | 2 | PS50280 | |
| Domain | C2 | 1.42e-02 | 131 | 26 | 2 | PF00168 | |
| Domain | C2 | 1.55e-02 | 137 | 26 | 2 | SM00239 | |
| Domain | C2 | 1.66e-02 | 142 | 26 | 2 | PS50004 | |
| Domain | - | 1.79e-02 | 148 | 26 | 2 | 2.60.40.150 | |
| Pubmed | Silencing of YY1 downregulates RIZ1 promoter in human osteosarcoma. | 5.80e-07 | 2 | 27 | 2 | 18488713 | |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | 4.17e-06 | 317 | 27 | 5 | 17620599 | |
| Pubmed | Yin Yang 1 extends the Myc-related transcription factors network in embryonic stem cells. | 5.80e-06 | 5 | 27 | 2 | 22210892 | |
| Pubmed | 8.79e-06 | 1429 | 27 | 8 | 35140242 | ||
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 8.86e-06 | 170 | 27 | 4 | 16159877 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 1.09e-05 | 1038 | 27 | 7 | 26673895 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.26e-05 | 398 | 27 | 5 | 35016035 | |
| Pubmed | The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase. | 2.44e-05 | 220 | 27 | 4 | 34091597 | |
| Pubmed | 2.60e-05 | 10 | 27 | 2 | 23333759 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 4.48e-05 | 1294 | 27 | 7 | 30804502 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 5.04e-05 | 1318 | 27 | 7 | 30463901 | |
| Pubmed | Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. | 5.68e-05 | 96 | 27 | 3 | 25948554 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 7.58e-05 | 954 | 27 | 6 | 36373674 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 8.24e-05 | 1425 | 27 | 7 | 30948266 | |
| Pubmed | A catalogue of putative HIV-1 protease host cell substrates. | 1.22e-04 | 124 | 27 | 3 | 22944692 | |
| Pubmed | 1.31e-04 | 652 | 27 | 5 | 31180492 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 1.59e-04 | 357 | 27 | 4 | 37059091 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | 1.86e-04 | 1124 | 27 | 6 | 21900206 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 2.00e-04 | 714 | 27 | 5 | 28302793 | |
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 2.01e-04 | 147 | 27 | 3 | 28977470 | |
| Pubmed | 2.08e-04 | 383 | 27 | 4 | 29331416 | ||
| Pubmed | Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition. | 2.17e-04 | 28 | 27 | 2 | 19596686 | |
| Pubmed | 2.17e-04 | 151 | 27 | 3 | 18457437 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 2.30e-04 | 736 | 27 | 5 | 29676528 | |
| Pubmed | 2.57e-04 | 754 | 27 | 5 | 35906200 | ||
| Pubmed | 2.72e-04 | 411 | 27 | 4 | 36652389 | ||
| Pubmed | Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome. | 2.84e-04 | 32 | 27 | 2 | 18809582 | |
| Pubmed | 2.84e-04 | 32 | 27 | 2 | 17267499 | ||
| Pubmed | 3.09e-04 | 425 | 27 | 4 | 21081503 | ||
| Pubmed | 3.19e-04 | 172 | 27 | 3 | 23184937 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 3.39e-04 | 1257 | 27 | 6 | 36526897 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 3.52e-04 | 440 | 27 | 4 | 34244565 | |
| Pubmed | 3.80e-04 | 37 | 27 | 2 | 23180766 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | 4.42e-04 | 1321 | 27 | 6 | 27173435 | |
| Pubmed | 4.68e-04 | 1335 | 27 | 6 | 29229926 | ||
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 4.74e-04 | 197 | 27 | 3 | 22365833 | |
| Pubmed | LINKIN, a new transmembrane protein necessary for cell adhesion. | 4.89e-04 | 480 | 27 | 4 | 25437307 | |
| Pubmed | 5.02e-04 | 201 | 27 | 3 | 25192599 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 5.02e-04 | 1353 | 27 | 6 | 29467282 | |
| Pubmed | 5.38e-04 | 44 | 27 | 2 | 30320934 | ||
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | 5.49e-04 | 495 | 27 | 4 | 28581483 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 5.55e-04 | 208 | 27 | 3 | 33230847 | |
| Pubmed | 5.63e-04 | 45 | 27 | 2 | 18922472 | ||
| Pubmed | 5.88e-04 | 46 | 27 | 2 | 16791210 | ||
| Pubmed | 5.88e-04 | 46 | 27 | 2 | 19928837 | ||
| Pubmed | 5.88e-04 | 46 | 27 | 2 | 20890123 | ||
| Pubmed | PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28γ. | 6.14e-04 | 47 | 27 | 2 | 29934401 | |
| Pubmed | FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis. | 6.88e-04 | 224 | 27 | 3 | 28443643 | |
| Pubmed | 7.03e-04 | 1442 | 27 | 6 | 35575683 | ||
| Interaction | UBA52 interactions | 1.31e-06 | 437 | 27 | 7 | int:UBA52 | |
| Interaction | MDM2 interactions | 1.92e-05 | 658 | 27 | 7 | int:MDM2 | |
| Interaction | SMN1 interactions | 4.29e-05 | 299 | 27 | 5 | int:SMN1 | |
| Cytoband | 1q21 | 1.32e-03 | 91 | 27 | 2 | 1q21 | |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | 1.97e-04 | 19 | 20 | 2 | 909 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 6.38e-04 | 34 | 20 | 2 | 487 | |
| Coexpression | HSIAO_HOUSEKEEPING_GENES | 4.77e-05 | 397 | 27 | 5 | M11197 | |
| Coexpression | GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_UP | 5.03e-05 | 200 | 27 | 4 | M7478 | |
| Coexpression | KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP | 5.54e-05 | 680 | 27 | 6 | M2107 | |
| ToppCell | ASK454-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.82e-05 | 149 | 27 | 3 | 078792d5272f1881757dc47daa96e87449cf5d34 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.08e-04 | 154 | 27 | 3 | 561d4d0481e47cf0dc86b09fba2b8f2b128377c9 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 170 | 27 | 3 | af8b56555cbd5a1016ab9ec2ce88225c58c89648 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-04 | 179 | 27 | 3 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | droplet-Spleen-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 181 | 27 | 3 | 14a04d8d69d3054b6ed3370d361dec5303ca4831 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 185 | 27 | 3 | 5414a66169c39d09a67b1050aad5e61f46b3749a | |
| ToppCell | droplet|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 185 | 27 | 3 | 4c8a25f36cbf43fc78d38dfeb3f1cab160bb029d | |
| ToppCell | Mild/Remission-B_intermediate-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.95e-04 | 188 | 27 | 3 | 614032d18f8060bb12d1af7a1cf1cf4d8b2b505b | |
| ToppCell | ILEUM-non-inflamed-(2)_Memory_B_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.98e-04 | 189 | 27 | 3 | 8d9b8a952db78646f137526f3175ba502f1d3692 | |
| ToppCell | droplet|World / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 189 | 27 | 3 | 6e779e4f9fed7b95c4cc975b1054331d507449b2 | |
| ToppCell | 368C-Lymphocytic-B_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.01e-04 | 190 | 27 | 3 | b9abf773525f7bbc87b8c0d4e94e9d18017de82b | |
| ToppCell | 368C-Lymphocytic-B_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.01e-04 | 190 | 27 | 3 | 1a016ae2603be5d024ba024faafd725787db8c48 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_T_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.01e-04 | 190 | 27 | 3 | 1c982eb37804532dec98db3a8e2f2184eb0f55fd | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-04 | 191 | 27 | 3 | 0e8a73f01e3ec95d242c09231bcf3790324d0a67 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_tracheobronchial_serous_cell-SMG_serous_(bronchial)-SMG_serous_(bronchial)_L.0.6.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-04 | 191 | 27 | 3 | 13460059a0c1ed9f476cef28b8ad4c06349056c6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.04e-04 | 191 | 27 | 3 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 191 | 27 | 3 | 4fcbc214853e115608b3be7b35639247ae41c9dc | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-04 | 191 | 27 | 3 | 54bbccc554f43ba2ebdf9ea191b94c8f16081b53 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.08e-04 | 192 | 27 | 3 | aee6522d25e012231cdb905ce047295cb64d6e82 | |
| ToppCell | ASK454-Immune-T_cell|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.11e-04 | 193 | 27 | 3 | 27c38a364bcdb4c0967155f18aa81d37e17c920b | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.14e-04 | 194 | 27 | 3 | 28c5482da199bcee9e85258a88af453d9fdbd56a | |
| ToppCell | PBMC-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 2.17e-04 | 195 | 27 | 3 | 674355ca00314bde90ef7f6ddb83afe2d5323130 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.17e-04 | 195 | 27 | 3 | 5f7d0b7d393d662fb346a4580c5189a044fedb16 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-T_lymphocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.17e-04 | 195 | 27 | 3 | c5e83251aa35cc0409e968ec08c7d78cbe35e37f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 195 | 27 | 3 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 195 | 27 | 3 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | metastatic_Brain-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 2.20e-04 | 196 | 27 | 3 | c17e105e47446a48aa06e1a3810828e20aa56ea9 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 196 | 27 | 3 | 81f9754567bbfa67edd304b9ef7b03e7bd9a3b52 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.20e-04 | 196 | 27 | 3 | 3a8bd09a09c19df27c954d448f1bae945314c221 | |
| ToppCell | facs-Brain_Non-Myeloid|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 197 | 27 | 3 | a1f7eec1aca03432caa8fe817ff6d24b29d4062d | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.24e-04 | 197 | 27 | 3 | 836dd8110d5689f944ad1d301def38c32278b5b5 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 2.24e-04 | 197 | 27 | 3 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 2.24e-04 | 197 | 27 | 3 | e666f6580e9a20b5e550f02125706db17eec8510 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 197 | 27 | 3 | e5ab45cfe4ebd02ca25029d87bece70dfbb4adc4 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature2_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.27e-04 | 198 | 27 | 3 | 89e25687b614525548279e5fa293c66f5c4abec3 | |
| ToppCell | lymphoid-T_cell-CD4+_Naive_T_cell|World / Lineage, cell class and subclass | 2.27e-04 | 198 | 27 | 3 | 32c6facead27d0d6ffbb1db571a102a6e66f502b | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.27e-04 | 198 | 27 | 3 | 24f6954aff8751885e783d68c631b04dd1980f48 | |
| ToppCell | severe-Myeloid-CD14_Monocytes_3|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.27e-04 | 198 | 27 | 3 | cb8f099cf4ed320615b1c60ddab86b89d8db9a43 | |
| ToppCell | control-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.27e-04 | 198 | 27 | 3 | 14bd612e9f9358ebff6cf8dda6a3165de9e4e3b0 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK|COVID-19_Convalescent / Disease group, lineage and cell class | 2.27e-04 | 198 | 27 | 3 | 457ba9e3f1bb6453af8cc1a6e7436af66296f8f5 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-04 | 198 | 27 | 3 | 0f25a3bf2af543267b43e56064ad06dfc18c7bd7 | |
| ToppCell | RV-12._Cytoplasmic_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.27e-04 | 198 | 27 | 3 | 4d5fdba7f11e35867bafcabbe1c841fec5a6ab88 | |
| ToppCell | RV-12._Cytoplasmic_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.27e-04 | 198 | 27 | 3 | 2499e182d39cc9940725170656b8a037fd8b94a5 | |
| ToppCell | Healthy_donor|World / disease group, cell group and cell class (v2) | 2.27e-04 | 198 | 27 | 3 | 1ed0b50c9754727a05c27b21f3546bf2e37eef7f | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.27e-04 | 198 | 27 | 3 | 4633e379893a26a746f8e29302cc54bbe04dd23f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature2_(2)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.27e-04 | 198 | 27 | 3 | a14d16d4755bd523d66e3b55e7d78cbb5359acfc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 2.31e-04 | 199 | 27 | 3 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | COVID-19_Severe-PLT_5|World / Disease Group and Platelet Clusters | 2.31e-04 | 199 | 27 | 3 | 937e4028f896bc6b751182517611825d6716c682 | |
| ToppCell | COVID-19_Severe-PLT_5|COVID-19_Severe / Disease Group and Platelet Clusters | 2.31e-04 | 199 | 27 | 3 | 93e814f45b220687007c75f20ec1ea25234f7d65 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 2.31e-04 | 199 | 27 | 3 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | BAL-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 2.31e-04 | 199 | 27 | 3 | da180aaa53f995183522da0f2321bf0c0c8ee6ec | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.31e-04 | 199 | 27 | 3 | 4366ead68736ae3a2cefac71fd349d526cccb611 | |
| ToppCell | Mild/Remission-B_intermediate-0|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.31e-04 | 199 | 27 | 3 | 592111591f0f6816fc56620cb555eb48dabf0758 | |
| ToppCell | healthy_donor|World / Disease condition, Lineage, Cell class and subclass | 2.34e-04 | 200 | 27 | 3 | afd4d5609adaa470e3d880f8be4a4d55e162b3d6 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK|COVID-19_Convalescent / Disease, condition lineage and cell class | 2.34e-04 | 200 | 27 | 3 | e94acbc62f8e9835413981ba6d0590a356afa05e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 2.34e-04 | 200 | 27 | 3 | 1cf8288c7cea9bfccd9f15f329743164e55fa595 | |
| ToppCell | Severe-B_intermediate-0|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.34e-04 | 200 | 27 | 3 | da37ca52b0121ab0fb6ae69626de51350e979a6a | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_submucosal-gland|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-04 | 200 | 27 | 3 | a3e044468de437948b63c517e0a4773cc247c906 | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells-Megakaryocyte|Megakaryo-cells / Lineage, cell class and subclass | 2.34e-04 | 200 | 27 | 3 | f36023bb369d17b8ec8724616737738e3df01987 | |
| ToppCell | Calu_3-uninfected|Calu_3 / Cell line, Condition and Strain | 2.34e-04 | 200 | 27 | 3 | cb9b6a6b085ae0e19b450940c4ecd92406d8a2b3 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.34e-04 | 200 | 27 | 3 | d254f6634895486f81d7a8b6f006fbc2679eaa5b | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.34e-04 | 200 | 27 | 3 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Sepsis-Bac-SEP|Sepsis / Disease, condition lineage and cell class | 2.34e-04 | 200 | 27 | 3 | 1f80e6a49c632b3ba0cdac1225c78e5d6d6d78a5 | |
| Disease | hip circumference | 2.07e-04 | 338 | 26 | 4 | EFO_0005093 | |
| Disease | Growth Disorders | 4.62e-04 | 36 | 26 | 2 | C0018273 | |
| Disease | Benign Neoplasm | 1.64e-03 | 68 | 26 | 2 | C0086692 | |
| Disease | Neoplasms | 1.64e-03 | 68 | 26 | 2 | C0027651 | |
| Disease | migraine disorder, endometriosis | 1.89e-03 | 73 | 26 | 2 | EFO_0001065, MONDO_0005277 | |
| Disease | Prostatic Neoplasms | 1.95e-03 | 616 | 26 | 4 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.95e-03 | 616 | 26 | 4 | C0376358 | |
| Disease | albuminuria | 3.10e-03 | 94 | 26 | 2 | EFO_0004285 | |
| Disease | Bell's palsy | 3.64e-03 | 102 | 26 | 2 | EFO_0007167 | |
| Disease | taste liking measurement | 4.69e-03 | 388 | 26 | 3 | EFO_0010155 | |
| Disease | Malignant Neoplasms | 5.67e-03 | 128 | 26 | 2 | C0006826 | |
| Disease | bitter alcoholic beverage consumption measurement | 6.11e-03 | 133 | 26 | 2 | EFO_0010092 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKLKYLHGQKKKGKD | 241 | P35869 | |
| KLSKVKHKAGKQGKG | 1836 | Q9P281 | |
| YGPKKKEKGMGKKGK | 411 | Q9NU02 | |
| KKPAAAKKGLGAKKG | 216 | Q8N6H7 | |
| RKYKGANKKGLSKGC | 96 | P23582 | |
| KVKWKGKGGKYTKSD | 321 | Q8WUA2 | |
| KGSPGGYLGAKKKKK | 36 | O60551 | |
| KTDKGDGKEKYRGLK | 21 | P54707 | |
| GKKFGNPGEKLVKKK | 31 | P17844 | |
| KKKFGKKNKDQGGLT | 266 | Q8TE67 | |
| YSKEKSSKKGKGKKK | 21 | P48167 | |
| KGKGKKSVQKSLYGE | 566 | Q69YH5 | |
| KKKGKKKKYTNSGTV | 271 | Q86YQ8 | |
| LKGKKFGPFVGDKKK | 51 | Q13029 | |
| YKLKSKPGKKDKERG | 126 | Q6WKZ4 | |
| GKEGDKYKLSKKELK | 21 | P23297 | |
| GKGKKKSKPVNKDRY | 81 | P62316 | |
| GAUGYKSKYLQLKKK | 11 | P63302 | |
| EKGLGKTTGKKLCYK | 46 | P30414 | |
| KGGKKGAKKKVVDPF | 11 | P61247 | |
| PGGGKKDDKDKKKKY | 11 | P62191 | |
| PGKKYKVKFDNKGKS | 226 | Q15047 | |
| RVKKGGGKKSGKKSY | 171 | P25490 | |
| GGKGGKKKKNKNSSK | 1046 | Q9HCK4 | |
| KKGKGQGKSHGKKQK | 6 | H3BMG3 | |
| KIKEPENYSKKGKGK | 211 | Q9H040 | |
| ENYSKKGKGKAKLGK | 216 | Q9H040 | |
| GYKSGKLKLKKPKQL | 416 | O43314 |